08 Cervical Cancer Clinical
CERVICAL CANCER
Clinical
1. Mohd Rushdan MN. Current status and future direction of cervical cancer prevention
program in Malaysia. 2008;.
2. Gita J, Razak A. Villoglandular adenocarcinoma of cervix--a tumour with bland
cytological features: report of a case missed on cytology. Malays J Pathol 2003;25(2):139143
http://www.mjpath.org.my/past_issue/MJP2003.2/07Case%20Report(Villoglandular).pdf.
3. Looi M, Ahmad Zailani Hatta, Mohd Dali, Siti Aishah MA, et al. Expression of p16 and pKi67 in cervical preneoplasia and neoplasia. Asia-Pacific Journal of Molecular Medicine
2011;1:1-7
http://journalarticle.ukm.my/3058/1/2011-1-6.pdf.
4. Cheah PL, Looi LM. Significance of Bcl-2 and Bax proteins in cervical carcinogenesis: an
immunohistochemical study in squamous cell carcinoma and squamous intraepithelial
lesions. Malays J Pathol 2006;28(1):1-5
http://www.mjpath.org.my/past_issue/MJP2006.1/01-Bcl-2.pdf.
5. Cheah PL, Looi LM, Mun KS, et al. Implications of continued upregulation of p16(INK4a)
through the evolution from high-grade squamous intraepithelial lesion to invasive
squamous carcinoma of the cervix. Malays J Pathol 2011;33(2):83-87
http://www.mjpath.org.my/2011.2/p16.pdf.
6. Mat-Isa NA, Mashor MY, Othman NH. An automated cervical pre-cancerous diagnostic
system. Artif Intell Med 2008;42(1):1-11.
7. Wong LP. Preventing cervical cancer through human papillomavirus vaccination:
perspective from focus groups. J Low Genit Tract Dis 2009;13(2):85-93.
8. El-Tawil SG, Adnan R, Muhamed ZN, et al. Comparative study between Pap smear
cytology and FTIR spectroscopy: a new tool for screening for cervical cancer. Pathology
2008;40(6):600-603.
9. Woo YL, Omar SZ. Human papillomavirus vaccination in the resourced and resourceconstrained world. Best Pract Res Clin Obstet Gynaecol 2011;25(5):597-603.
10. Wong LP, Wong YL, Low WY, et al. Cervical cancer screening attitudes and beliefs of
Malaysian women who have never had a pap smear: a qualitative study. Int J Behav Med
2008;15(4):289-292.
11. Wong YL, Chinna K, Mariapun J, et al. Correlates between risk perceptions of cervical
cancer and screening practice. Prev Med 2013;57 Suppl:S24-6.
12. Woo YL, Badley C, Jackson E, et al. Long-term cytological and histological outcomes in
women managed with loop excision treatment under local anaesthetic for high-grade
cervical intraepithelial neoplasia. Cytopathology 2011;22(5):334-339.
13. Looi ML, Karsani SA, Rahman MA, et al. Plasma proteome analysis of cervical
intraepithelial neoplasia and cervical squamous cell carcinoma. J Biosci 2009;34(6):917925.
14. Cheah PL, Looi LM. P53 immunohistochemical expression: messages in cervical
carcinogenesis. Pathology 2002;34(4):326-331.
15. Tan GC, Isa MR, Ng SP, et al. Unusual form of superficial spreading microinvasive
squamous cell carcinoma of uterine cervix involving the endometrium of uterus. J Obstet
Gynaecol Res 2004;30(5):363-367.
16. Dunn RA, Tan AK. Cervical cancer screening in Malaysia: Are targeted interventions
necessary? Soc Sci Med 2010;71(6):1089-1093.
17. Looi ML, Dali AZ, Ali SA, et al. Expression of p53, bcl-2 and Ki-67 in cervical
intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Anal
Quant Cytol Histol 2008;30(2):63-70.
18. Nor Hayati O. Cancer of the cervix - from bleak past to bright future; a review, with an
emphasis on cancer of the cervix in malaysia. Malays J Med Sci 2003;10(1):13-26
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557105/pdf/mjms-10-1-013.pdf.
19. Nor Hayati O. Cervical cancer - understanding its molecular genesis and proposing the
use of molecular pap smear in Malaysia. Genetik 2004;10(2):1
http://www.persatuangenetikmalaysia.com/bulletindec04.pdf.
20. Sivanesaratnam V. Management of the pregnant mother with malignant conditions.
Curr Opin Obstet Gynecol 2001;13(2):121-125.
21. Lokamani I, Looi ML, Ali SA, et al. Clusterin as a potential marker in distinguishing
cervical neoplasia. Anal Quant Cytol Histol 2011;33(4):223-228.
22. Al-Naggar RA, Low WY, Zaleha MI. Knowledge and barriers towards cervical cancer
screening among young women in Malaysia. Asian Pac J Cancer Prev 2010;11(4):867-873
http://www.apocpcontrol.com/paper_file/issue_abs/Volume11_No4/c%20867873%20Low.pdf.
23. Tan YY, Hesham R, Qodriyah HM. Knowledge and attitude of university students in
health sciences on the prevention of cervical cancer. Med J Malaysia 2010;65(1):53-57
http://www.e-mjm.org/2010/v65n1/Cervical_cancer.pdf.
24. Tran NT, Choe SI, Taylor R, et al. Knowledge, attitude and practice (KAP) concerning
cervical cancer and screening among rural and urban women in six provinces of the
Democratic People's Republic of Korea. Asian Pac J Cancer Prev 2011;12(11):3029-3033.
25. Looi ML, Mohd Dali AZ, Md Ali SA, et al. Oxidative damage and antioxidant status in
patients with cervical intraepithelial neoplasia and carcinoma of the cervix. Eur J Cancer
Prev 2008;17(6):555-560.
26. Abdul-Rahman PS, Lim BK, Hashim OH. Expression of high-abundance proteins in sera
of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining
and lectin detection methods. Electrophoresis 2007;28(12):1989-1996.
27. Sudirman A, Sukumar N, Davaraj B. Appendicular metastasis from carcinoma cervix.
Med J Malaysia 2001;56(1):100-101
http://www.e-mjm.org/2001/v56n1/Carcinoma_Cervix.pdf.
28. Wong LP, Wong YL, Low WY, et al. Knowledge and awareness of cervical cancer and
screening among Malaysian women who have never had a Pap smear: a qualitative study.
Singapore Med J 2009;50(1):49-53
http://smj.sma.org.sg/5001/5001a6.pdf.
29. Hayati AR, Zulkarnaen M. An immunohistochemical study of CD1a and CD83-positive
infiltrating dendritic cell density in cervical neoplasia. Int J Gynecol Pathol 2007;26(1):8388.
30. Abu Backer FM, Mustapha NR, Othman NH. Combined expression of p161NK4a and
p27Kip1, but not p21WAF1, differentiates endocervical from endometrial adenocarcinoma.
Anal Quant Cytol Histol 2011;33(5):283-288.
31. Afzan MY, Suresh K. Pseudocyst forms of Trichomonas vaginalis from cervical
neoplasia. Parasitol Res 2012;111(1):371-381.
32. Yusof AM, Kumar S. Phenotypic 'variant' forms of Trichomonas vaginalis trophozoites
from cervical neoplasia patients. Exp Parasitol 2012;131(3):267-273.
33. Lee MY, Telisinghe PU, Ramasamy R. Cervical cancer in Brunei Darussalam. Singapore
Med J 2012;53(9):604-607
http://www.ncbi.nlm.nih.gov/pubmed/23023903.
34. Wong LP, Sam I-. Current issues facing the introduction of human papillomavirus
vaccine in Malaysia. Malaysian Family Physician 2007;2(2):47-53
http://www.scopus.com/inward/record.url?eid=2-s2.043049118267&partnerID=40&md5=1d9130dae890050b6ffb2a851f87a9e5.
35. Al-Dubai SAR, Alshagga MA, Al-Naggar RA, et al. Knowledge, attitudes and barriers for
human papilloma virus (HPV) vaccines among Malaysian women. Asian Pac J Cancer Prev
2010;11(4):887-892
http://www.apocp.org/cancer_download/Volume11_No4/c%20887-92%20%20Al-Dubai.pdf.
36. Sivalingam N. Clinical Practice Guidelines on Management of Cervical Cancer. 2003;.
37. Fauzi AN, Norazmi MN, Yaacob NS. Tualang honey induces apoptosis and disrupts the
mitochondrial membrane potential of human breast and cervical cancer cell lines. Food
Chem Toxicol 2011;49(4):871-878.
38. Ng WK, Yazan LS, Ismail M. Thymoquinone from Nigella sativa was more potent than
cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.
Toxicol In Vitro 2011;25(7):1392-1398.
39. Abdelwahab SI, Abdul AB, Zain ZN, et al. Zerumbone inhibits interleukin-6 and induces
apoptosis and cell cycle arrest in ovarian and cervical cancer cells. Int Immunopharmacol
2012;12(4):594-602.
40. Abdelwahab SI, Abdul AB, Devi N, et al. Regression of cervical intraepithelial neoplasia
by zerumbone in female Balb/c mice prenatally exposed to diethylstilboestrol: involvement
of mitochondria-regulated apoptosis. Exp Toxicol Pathol 2010;62(5):461-469.
41. Nieuwenhuizen L, Khalil MK, Venkatesh N, et al. Endometrial and endocervical
secretion: the search for histochemical differentiation. Anal Quant Cytol Histol
2006;28(2):87-96.
42. Devi BC, Tang TS, Corbex M. Reducing by half the percentage of late-stage
presentation for breast and cervix cancer over 4 years: a pilot study of clinical
downstaging in Sarawak, Malaysia. Ann Oncol 2007;18(7):1172-1176.
43. Marjmin O, Badrulhisham B, Teoh CM, et al. Metastatic cervical carcinoma in the
caecum. Med J Malaysia 2005;60(1):97-98
http://www.e-mjm.org/2005/v60n1/Metastatic_Cervical_Carcinoma.pdf.
44. Rushdan MN, Tay EH, Khoo-Tan HS, et al. Tailoring the field and indication of adjuvant
pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma
following radical surgery based on the GOG score--a pilot study. Ann Acad Med Singapore
2004;33(4):467-472.
45. Asma A, Maizaton AA. Kimura's disease: an unusual cause of cervical tumor. Med J
Malaysia 2005;60(3):373-376
http://www.e-mjm.org/2005/v60n3/Kimuras_Disease.pdf.
46. Ab Hamid S, Wastie ML. Primary non-Hodgkin's lymphoma presenting as a uterine
cervical mass. Singapore Med J 2008;49(3):e73-5
http://smj.sma.org.sg/4903/4903cr4.pdf.
47. Shanthi V, Majdah M, Syed Aljunid, et al. Cervical cancer in Malaysia: can we improve
our screening and preventive practice? BMC Public Health 2012;12(Suppl 2):A17
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507984/pdf/1471-2458-12-S2-A17.pdf.
48. Sharifa Ezat WP, Aljunid SM, Ng P, et al. Quality of life among preinvasive and invasive
cervical cancer in Malaysia. ASEAN Journal of Psychiatry 2009;10(2):115-126
http://www.aseanjournalofpsychiatry.org/pdf/2ASEAN_3_Ezat.pdf.
49. Devi Beena CR, Tang TS, Gerard LC. Preliminary results from the pilot study on the
National Cancer Patient Registry--Cervical Cancer. Med J Malaysia 2008;63 Suppl C:63-65
50. Norodiyah O, Othman NH. Adequacy of cellular material in split-sampling of cervical
scrapings for routine cancer screening: an analysis of 702 smears. Malays J Pathol
2012;34(2):115-121
http://www.mjpath.org.my/2012.2/cancer-screening.pdf.
51. Saini R, Shen TH, Othman NH, et al. Evaluation of polymerase chain reaction (PCR)
method and hybrid capture II (HCII) assay for the detection of human papillomavirus in
cervical scrapings. Med J Malaysia 2007;62(3):206-209
http://www.e-mjm.org/2007/v62n3/Human_Papillomavirus.pdf.
52. Tran NT, Taylor R, Choe SI, et al. Knowledge, attitude and practice (KAP) concerning
cervical cancer and screening among rural and urban female healthcare practitioners in
the Democratic People's Republic of Korea. Asian Pac J Cancer Prev 2011;12(11):30233028.
53. Quek SC, Lim BK, Domingo E, et al. Human papillomavirus type distribution in invasive
cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
Int J Gynecol Cancer 2013;23(1):148-156.
54. Chong PP, Asyikin N, Rusinahayati M, et al. High prevalence of human papillomavirus
DNA detected in cervical swabs from women in southern Selangor, Malaysia. Asian Pac J
Cancer Prev 2010;11(6):1645-1651
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%20164551%2011.03%20P%20P%20Chong.pdf.
55. Cheah PL, Looi LM, Sivanesaratnam V. Human papillomavirus in cervical cancers of
Malaysians. J Obstet Gynaecol Res 2011;37(6):489-495.
56. Tay SK, Tay YK. The prevalence and significance of high-risk human papillomavirus DNA
test in southern Malaysia and Singapore. Aust N Z J Obstet Gynaecol 2009;49(3):323-327.
57. Chow SN, Soon R, Park JS, et al. Knowledge, attitudes, and communication around
human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians.
Vaccine 2010;28(22):3809-3817.
58. Wong LP, Sam IC. Ethnically diverse female university students' knowledge and
attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J
Obstet Gynecol Reprod Biol 2010;148(1):90-95.
59. Farzaneh F, Shirvani HE, Barouti E, et al. Knowledge and attitude of women regarding
the human papillomavirus (HPV) infection, its relationship to cervical cancer and
prevention methods. Med J Malaysia 2011;66(5):468-473
http://www.e-mjm.org/2011/v66n5/Human_Papillomavirus.pdf.
60. Naing C, Pereira J, Abe T, et al. Predictors associated with the willingness to take
human papilloma virus vaccination. J Community Health 2012;37(2):288-293.
61. Wong LP. Knowledge and attitudes about HPV infection, HPV vaccination, and cervical
cancer among rural southeast Asian women. Int J Behav Med 2011;18(2):105-111.
62. Sam IC, Wong LP, Rampal S, et al. Maternal acceptance of human papillomavirus
vaccine in Malaysia. J Adolesc Health 2009;44(6):610-612.
63. Wong LP. HPV information needs, educational messages and channel of delivery
preferences: views from developing country with multiethnic populations. Vaccine
2009;27(9):1410-1415.
64. Domingo EJ, Noviani R, Noor MR, et al. Epidemiology and prevention of cervical cancer
in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine 2008;26 Suppl
12:M71-9.
65. Wong LP. Physicians' experiences with HPV vaccine delivery: evidence from developing
country with multiethnic populations. Vaccine 2009;27(10):1622-1627.
HEALTH BEHAVIOUR:
66. Nor Hayati O, Beena CD, Halimah Y. Cervical cancer screening: patients understanding
in major hospitals in Malaysia. Asian Pac J Cancer Prev 2009;10(4):569-574
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No4/c
%20569%20Othman.pdf.
67. Rima Marhayu AR, Majdah M, Zaleha AH, et al. Is the phone call the most effective
method for recall in cervical cancer screening? - results from a randomised control trial.
Asian Pac J Cancer Prev 2013;14(10):5901-5904
http://www.ncbi.nlm.nih.gov/pubmed/24289597
68. Rima Marhayu AR, Maznah D. Study protocol for the most effective recall method in a
cervical cancer screening program in Klang, Malaysia. Asian Pac J Cancer Prev
2013;14(10):5867-5870
http://www.ncbi.nlm.nih.gov/pubmed/24289591
69. Rima Marhayu AR, Maznah D, Majdah M, et al. Adapting the Australian system: is an
organized screening program feasible in Malaysia?--an overview of cervical cancer
screening in both countries. Asian Pac J Cancer Prev 2013;14(3):2141-2146
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No3/21412146%202.5%20Rima%20Marhayu%20Abdul%20Rashid_1.pdf.
70. Al-Naggar RA, Al-Jashamy K, Chen R. Perceptions and opinions regarding human
papilloma virus vaccination among young women in Malaysia. Asian Pac J Cancer Prev
2010;11(6):1515-1521
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%20151521%2010.21%20Redhwan%20Ahmed%20Al-Naggar.pdf.
71. Farveen Marican AB, Nik Raihan NM, Nor Hayati O. Clinicopathological comparison of
adenocarcinoma of cervix and endometrium using cell cycle markers: P16ink4a, P21waf1,
and p27Kip1 on 132 cancers. Infect Dis Obstet Gynecol 2011;2011:857851
http://web.ebscohost.com.ezp.imu.edu.my/ehost/pdfviewer/pdfviewer?sid=71afbef8-5f1c44f2-9fd8-5931a898c0b7%40sessionmgr4003&vid=4&hid=4112.
72. Nuradhiathy AR, Khattak M, Yong Zulina Z, et al. Estimating the five-year survival of
cervical cancer patients treated in hospital universiti sains malaysia. Asian Pac J Cancer
Prev 2013;14(2):825-828
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/82528%201.15%20Nuradhiathy%20Abd%20Razak.pdf.
73. Woo YL, Sharina MR, Chong KR, et al. Does the success of a school-based HPV vaccine
programme depend on teachers' knowledge and religion? -- A survey in a multicultural
society. Asian Pac J Cancer Prev 2012;13(9):4651-4654
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No9/4651-54%208.13%20Yin
%20Ling%20Woo.pdf.
74. Al-Naggar RA, Bobryshev YV, Al-Jashamy K, et al. Practice of HPV vaccine and
associated factors among school girls in Melaka, Malaysia. Asian Pac J Cancer Prev
2012;13(8):3835-3840
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/383540%205.7%20Redhwan%20Ahmed%20Al-Naggar%20%28girls%20in%20Malaka%29.pdf.
HEALTH BEHAVIOUR:
75. Hesham HR, Nur Zakiah, N Mohd Saat, Dahlia Nadira AM. Knowledge, attitude and
practice of malaysian medical and pharmacy students towards human papillomavirus
vaccination. Asian Pac J Cancer Prev 2012;13(5):2279-2283
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No5/227983%2010.6%20Hesham%20H%20Rashwan.pdf.
76. Al-Naggar RA, Bobryshev YV. Practice towards human papillomavirus vaccines among
Malaysian women: a survey of a general youth population. Asian Pac J Cancer Prev
2011;12(8):2045-2049
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No8/2045-49%20c7.30%20AlNaggar.pdf.
77. Hesham R, Syarif Husin L, Kiat AN. Knowledge of cervical cancer and acceptance of
HPV vaccination among secondary school students in Sarawak, Malaysia. Asian Pac J
Cancer Prev 2011;12(7):1837-1841
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No7/1837-1841%20c
%206.27%20Hesham%20Rashwan.pdf
78. Khoo CL, Teoh S, Abdul Rashid Khan, et al. Awareness of cervical cancer and HPV
vaccination and its affordability among rural folks in Penang Malaysia. Asian Pac J Cancer
Prev 2011;12(6):1429-1433
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No6/1429-1433%20c
%205.11%20Chung%20Lee%20Khoo.pdf.
79. Fauziah A, Norlaili AA, Su TT. Factors related to poor practice of Pap smear screening
among secondary school teachers in Malaysia. Asian Pac J Cancer Prev 2011;12(5):13471352
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No5/1347-1352%20c
%204.17%20Fauziah%20Abdullah.pdf.
80. Syed M Aljunid, Zafar A, Saperi S, et al. Burden of disease associated with cervical
cancer in Malaysia and potential costs and consequences of HPV vaccination. Asian Pac J
Cancer Prev 2010;11(6):1551-1559
www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c 1551-59 10.25 S Aljunid.pdf.
81. Fauziah A, Su TT. Enhancement of the cervical cancer screening program in Malaysia: a
qualitative study. Asian Pac J Cancer Prev 2010;11(5):1359-1366
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No5/c%201359-66%20Fauziah
%20Abdullah.pdf.
82. Sharifa Ezat WP, Syed Aljunid. Cost-effectiveness of HPV vaccination in the prevention
of cervical cancer in Malaysia. Asian Pac J Cancer Prev 2010;11(1):79-90
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No1/79%20c%20Sharif
%20Ezat.pdf.
83. Sharifa Ezat WP, Syed Aljunid. Comparative cost-effectiveness of HPV vaccines in the
prevention of cervical cancer in Malaysia. Asian Pac J Cancer Prev 2010;11(4):943-951
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No4/c%20943-51%20Ezat.pdf.
84. Sharifa Ezat WP, Rozita H, Jamsiah M, et al. National HPV immunisation programme:
knowledge and acceptance of mothers attending an obstetrics clinic at a teaching
hospital, Kuala Lumpur. Asian Pac J Cancer Prev 2013;14(5):2991-2999
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No5/299199%204.8%20Sharifa%20Ezat%20.pdf
85. Nor Hayati O, Rebolj M. Challenges to cervical screening in a developing country: the
case of Malaysia. Asian Pac J Cancer Prev 2009;10(5):747-752
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No5/747%20c%20Nor
%20Hayati%20.pdf.
86. Sharifah Noor Akmal, Seeni A, Nurismah M, et al. Prevalence of human papillomavirus
in abnormal cervical smears in Malaysian patients. Asian Pac J Cancer Prev
2009;10(2):303-306.
87. Sharifa Ezat WP, Sharifah NA, Sayyidi Hamzi A, et al. Prevalence of human
papillomavirus genotypes in preinvasive and invasive cervical cancer-A UKM study. Med
Health 2010;5(2):66-76
http://journalarticle.ukm.my/2071/1/06-MS_084_-_proof__66-76_.pdf.
88. Tan GC, Sharifah Noor Akmal, Shiran MS, et al. Utility of Ki-67 and p53 in distinguishing
cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix. Asian Pac J
Cancer Prev 2008;9(4):781-784
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No4/781%20c%20Tan.pdf.
89. Mohamad Nasir S, Nazimah I, Rushdan MN. The Role of Computed Tomography (CT)
Scan in Assessment of the Parametrial Involvement in Early Stage Cervical Carcinoma.
Journal of Surgical Academia 2012;2(1):14
http://journalarticle.ukm.my/5179/1/04-MS1056%2814-17%29.pdf.
90. Shafiee M, NorAzlin M, Lim P, et al. Emergency chemotherapy’ for bleeding cervical
cancer: case series. Journal of Surgical Academia 2012;2(2):35
http://journalarticle.ukm.my/5942/1/09-MS1066_%2835-37%29_1.pdf.
91. Aishah AM, Osman A. Knowledge, attitude and practice among midwives and
community nurses on cervical cancer in the state of Kedah in 1997. Jurnal Kesihatan
Masyarakat 2006;12(1).
92. Al-Jashamy K, Al-Naggar RA, San P, et al. Histopathological findings for cervical lesions
in Malaysian women. Asian Pac J Cancer Prev 2009;10(6):1159-1162
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No6/1159_c_Al-Jashamy.pdf.
93. Rima Marhayu AR, Majdah M, Zaleha AH, et al. Is the phone call the most effective
method for recall in cervical cancer screening? - results from a randomised control trial.
Asian Pac J Cancer Prev 2013;14(10):5901-5904
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No10/59015904%207.17%20Rima%20Marhayu%20Abdul%20Rashid.pdf.
94. Sharifa Ezat WP, Norin Rahayu S, Sharifah Noor Akmal, Syed Hussain, et al. HPV
Positivity and its’ Influencing factors among invasive cervical cancer women in Malaysia.
International Journal of Public Health Research. International Journal of Public Health
Research 2011;1(1):13
http://journalarticle.ukm.my/3340/1/vol%25201%2520no%25201%25202011_3.pdf.
95. Ahmad Bustamam A, Abdelwahab SI, Johari J, et al. Combination of zerumbone and
cisplatin to treat cervical intraepithelial neoplasia in female BALB/c mice. Int J Gynecol
Cancer 2009;19(6):1004-1010
http://ovidsp.tx.ovid.com.ezp.imu.edu.my/sp
3.10.0b/ovidweb.cgi?
WebLinkFrameset=1&S=GIPIFPAMIPDDPEEINCNKLEJCOPCJAA00&returnUrl=ovidweb.cgi
%3f%26Titles%3dS.sh.43%257c1%257c10%26FORMAT%3dtitle%26FIELDS%3dTITLES
%26S%3dGIPIFPAMIPDDPEEINCNKLEJCOPCJAA00&directlink=http%3a%2f
%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCJCLEEIIP00%2ffs047%2fovft%2flive
%2fgv031%2f00009577%2f00009577-20090800000004.pdf&filename=Combination+of+Zerumbone+and+Cisplatin+to+Treat+Cervical+In
traepithelial+Neoplasia+in+Female+BALB
%2fc+Mice.&navigation_links=NavLinks.S.sh.43.1&PDFIdLinkField=%2ffs047%2fovft
%2flive%2fgv031%2f00009577%2f00009577200908000-00004&link_from=S.sh.43; 1&pdf_key=B&pdf_index=S.sh.43&D=yrovft.
96. Al-Naggar RA, Zaleha MI. Perception and opinion of medical students about Pap smear
test: a qualitative study. Asian Pac J Cancer Prev 2010;11(2):435-440
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No2/435%20Redhwan
%20Ahmed%20Al-Naggar.pdf.
97. Alsaad MA, Khadijah S, Fariza F. Knowledge towards HPV infection and HPV vaccines
among Syrian mothers. Asian Pac J Cancer Prev 2012;13(3):879-883
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No3/87983%202.17%20Mohammed%20Alsaad.pdf.
98. Cheah PL, Looi L, Teoh KH, et al. p16(INK4a) is a useful marker of human
papillomavirus integration allowing risk stratification for cervical malignancies. Asian Pac J
Cancer Prev 2012;13(2):469-472
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No2/46972%201.9%20Cheah.pdf.
99. Rashwan H, Ishak I, Sawalludin N. Knowledge and views of secondary school students
in Kuala Lumpur on cervical cancer and its prevention. Asian Pac J Cancer Prev
2013;14(4):2545-2549.
100. Cheah PL, Looi LM, Ng MH, et al. Telomerase activation and human papillomavirus
infection in invasive uterine cervical carcinoma in a set of Malaysian patients. J Clin Pathol
2002;55(1):22-26
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769559/.
101. Farooqui M, Hassali MA, Knight A, et al. A qualitative exploration of Malaysian cancer
patients' perceptions of cancer screening. BMC Public Health 2013;13:48-2458-13-48
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564681/.
102. Gravitt PE. Evidence and impact of human papillomavirus latency. Open Virol J
2012;6:198-203
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547385/.
103. Gravitt PE. The known
2011;121(12):4593-4599
unknowns
of
HPV
natural
history.
J
Clin
Invest
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225991/.
104. Ramasamy S, Abdul Wahab N, Zainal Abidin N, et al. Growth inhibition of human
gynecologic and colon cancer cells by Phyllanthus watsonii through apoptosis induction.
PLoS One 2012;7(4):e34793
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335034/.
105. Saini R, Khim TP, Rahman SA, et al. High-risk human papillomavirus in the oral cavity
of women with cervical cancer, and their children. Virol J 2010;7:131-422X-7-131
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901268/.
Clinical
1. Mohd Rushdan MN. Current status and future direction of cervical cancer prevention
program in Malaysia. 2008;.
2. Gita J, Razak A. Villoglandular adenocarcinoma of cervix--a tumour with bland
cytological features: report of a case missed on cytology. Malays J Pathol 2003;25(2):139143
http://www.mjpath.org.my/past_issue/MJP2003.2/07Case%20Report(Villoglandular).pdf.
3. Looi M, Ahmad Zailani Hatta, Mohd Dali, Siti Aishah MA, et al. Expression of p16 and pKi67 in cervical preneoplasia and neoplasia. Asia-Pacific Journal of Molecular Medicine
2011;1:1-7
http://journalarticle.ukm.my/3058/1/2011-1-6.pdf.
4. Cheah PL, Looi LM. Significance of Bcl-2 and Bax proteins in cervical carcinogenesis: an
immunohistochemical study in squamous cell carcinoma and squamous intraepithelial
lesions. Malays J Pathol 2006;28(1):1-5
http://www.mjpath.org.my/past_issue/MJP2006.1/01-Bcl-2.pdf.
5. Cheah PL, Looi LM, Mun KS, et al. Implications of continued upregulation of p16(INK4a)
through the evolution from high-grade squamous intraepithelial lesion to invasive
squamous carcinoma of the cervix. Malays J Pathol 2011;33(2):83-87
http://www.mjpath.org.my/2011.2/p16.pdf.
6. Mat-Isa NA, Mashor MY, Othman NH. An automated cervical pre-cancerous diagnostic
system. Artif Intell Med 2008;42(1):1-11.
7. Wong LP. Preventing cervical cancer through human papillomavirus vaccination:
perspective from focus groups. J Low Genit Tract Dis 2009;13(2):85-93.
8. El-Tawil SG, Adnan R, Muhamed ZN, et al. Comparative study between Pap smear
cytology and FTIR spectroscopy: a new tool for screening for cervical cancer. Pathology
2008;40(6):600-603.
9. Woo YL, Omar SZ. Human papillomavirus vaccination in the resourced and resourceconstrained world. Best Pract Res Clin Obstet Gynaecol 2011;25(5):597-603.
10. Wong LP, Wong YL, Low WY, et al. Cervical cancer screening attitudes and beliefs of
Malaysian women who have never had a pap smear: a qualitative study. Int J Behav Med
2008;15(4):289-292.
11. Wong YL, Chinna K, Mariapun J, et al. Correlates between risk perceptions of cervical
cancer and screening practice. Prev Med 2013;57 Suppl:S24-6.
12. Woo YL, Badley C, Jackson E, et al. Long-term cytological and histological outcomes in
women managed with loop excision treatment under local anaesthetic for high-grade
cervical intraepithelial neoplasia. Cytopathology 2011;22(5):334-339.
13. Looi ML, Karsani SA, Rahman MA, et al. Plasma proteome analysis of cervical
intraepithelial neoplasia and cervical squamous cell carcinoma. J Biosci 2009;34(6):917925.
14. Cheah PL, Looi LM. P53 immunohistochemical expression: messages in cervical
carcinogenesis. Pathology 2002;34(4):326-331.
15. Tan GC, Isa MR, Ng SP, et al. Unusual form of superficial spreading microinvasive
squamous cell carcinoma of uterine cervix involving the endometrium of uterus. J Obstet
Gynaecol Res 2004;30(5):363-367.
16. Dunn RA, Tan AK. Cervical cancer screening in Malaysia: Are targeted interventions
necessary? Soc Sci Med 2010;71(6):1089-1093.
17. Looi ML, Dali AZ, Ali SA, et al. Expression of p53, bcl-2 and Ki-67 in cervical
intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Anal
Quant Cytol Histol 2008;30(2):63-70.
18. Nor Hayati O. Cancer of the cervix - from bleak past to bright future; a review, with an
emphasis on cancer of the cervix in malaysia. Malays J Med Sci 2003;10(1):13-26
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557105/pdf/mjms-10-1-013.pdf.
19. Nor Hayati O. Cervical cancer - understanding its molecular genesis and proposing the
use of molecular pap smear in Malaysia. Genetik 2004;10(2):1
http://www.persatuangenetikmalaysia.com/bulletindec04.pdf.
20. Sivanesaratnam V. Management of the pregnant mother with malignant conditions.
Curr Opin Obstet Gynecol 2001;13(2):121-125.
21. Lokamani I, Looi ML, Ali SA, et al. Clusterin as a potential marker in distinguishing
cervical neoplasia. Anal Quant Cytol Histol 2011;33(4):223-228.
22. Al-Naggar RA, Low WY, Zaleha MI. Knowledge and barriers towards cervical cancer
screening among young women in Malaysia. Asian Pac J Cancer Prev 2010;11(4):867-873
http://www.apocpcontrol.com/paper_file/issue_abs/Volume11_No4/c%20867873%20Low.pdf.
23. Tan YY, Hesham R, Qodriyah HM. Knowledge and attitude of university students in
health sciences on the prevention of cervical cancer. Med J Malaysia 2010;65(1):53-57
http://www.e-mjm.org/2010/v65n1/Cervical_cancer.pdf.
24. Tran NT, Choe SI, Taylor R, et al. Knowledge, attitude and practice (KAP) concerning
cervical cancer and screening among rural and urban women in six provinces of the
Democratic People's Republic of Korea. Asian Pac J Cancer Prev 2011;12(11):3029-3033.
25. Looi ML, Mohd Dali AZ, Md Ali SA, et al. Oxidative damage and antioxidant status in
patients with cervical intraepithelial neoplasia and carcinoma of the cervix. Eur J Cancer
Prev 2008;17(6):555-560.
26. Abdul-Rahman PS, Lim BK, Hashim OH. Expression of high-abundance proteins in sera
of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining
and lectin detection methods. Electrophoresis 2007;28(12):1989-1996.
27. Sudirman A, Sukumar N, Davaraj B. Appendicular metastasis from carcinoma cervix.
Med J Malaysia 2001;56(1):100-101
http://www.e-mjm.org/2001/v56n1/Carcinoma_Cervix.pdf.
28. Wong LP, Wong YL, Low WY, et al. Knowledge and awareness of cervical cancer and
screening among Malaysian women who have never had a Pap smear: a qualitative study.
Singapore Med J 2009;50(1):49-53
http://smj.sma.org.sg/5001/5001a6.pdf.
29. Hayati AR, Zulkarnaen M. An immunohistochemical study of CD1a and CD83-positive
infiltrating dendritic cell density in cervical neoplasia. Int J Gynecol Pathol 2007;26(1):8388.
30. Abu Backer FM, Mustapha NR, Othman NH. Combined expression of p161NK4a and
p27Kip1, but not p21WAF1, differentiates endocervical from endometrial adenocarcinoma.
Anal Quant Cytol Histol 2011;33(5):283-288.
31. Afzan MY, Suresh K. Pseudocyst forms of Trichomonas vaginalis from cervical
neoplasia. Parasitol Res 2012;111(1):371-381.
32. Yusof AM, Kumar S. Phenotypic 'variant' forms of Trichomonas vaginalis trophozoites
from cervical neoplasia patients. Exp Parasitol 2012;131(3):267-273.
33. Lee MY, Telisinghe PU, Ramasamy R. Cervical cancer in Brunei Darussalam. Singapore
Med J 2012;53(9):604-607
http://www.ncbi.nlm.nih.gov/pubmed/23023903.
34. Wong LP, Sam I-. Current issues facing the introduction of human papillomavirus
vaccine in Malaysia. Malaysian Family Physician 2007;2(2):47-53
http://www.scopus.com/inward/record.url?eid=2-s2.043049118267&partnerID=40&md5=1d9130dae890050b6ffb2a851f87a9e5.
35. Al-Dubai SAR, Alshagga MA, Al-Naggar RA, et al. Knowledge, attitudes and barriers for
human papilloma virus (HPV) vaccines among Malaysian women. Asian Pac J Cancer Prev
2010;11(4):887-892
http://www.apocp.org/cancer_download/Volume11_No4/c%20887-92%20%20Al-Dubai.pdf.
36. Sivalingam N. Clinical Practice Guidelines on Management of Cervical Cancer. 2003;.
37. Fauzi AN, Norazmi MN, Yaacob NS. Tualang honey induces apoptosis and disrupts the
mitochondrial membrane potential of human breast and cervical cancer cell lines. Food
Chem Toxicol 2011;49(4):871-878.
38. Ng WK, Yazan LS, Ismail M. Thymoquinone from Nigella sativa was more potent than
cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.
Toxicol In Vitro 2011;25(7):1392-1398.
39. Abdelwahab SI, Abdul AB, Zain ZN, et al. Zerumbone inhibits interleukin-6 and induces
apoptosis and cell cycle arrest in ovarian and cervical cancer cells. Int Immunopharmacol
2012;12(4):594-602.
40. Abdelwahab SI, Abdul AB, Devi N, et al. Regression of cervical intraepithelial neoplasia
by zerumbone in female Balb/c mice prenatally exposed to diethylstilboestrol: involvement
of mitochondria-regulated apoptosis. Exp Toxicol Pathol 2010;62(5):461-469.
41. Nieuwenhuizen L, Khalil MK, Venkatesh N, et al. Endometrial and endocervical
secretion: the search for histochemical differentiation. Anal Quant Cytol Histol
2006;28(2):87-96.
42. Devi BC, Tang TS, Corbex M. Reducing by half the percentage of late-stage
presentation for breast and cervix cancer over 4 years: a pilot study of clinical
downstaging in Sarawak, Malaysia. Ann Oncol 2007;18(7):1172-1176.
43. Marjmin O, Badrulhisham B, Teoh CM, et al. Metastatic cervical carcinoma in the
caecum. Med J Malaysia 2005;60(1):97-98
http://www.e-mjm.org/2005/v60n1/Metastatic_Cervical_Carcinoma.pdf.
44. Rushdan MN, Tay EH, Khoo-Tan HS, et al. Tailoring the field and indication of adjuvant
pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma
following radical surgery based on the GOG score--a pilot study. Ann Acad Med Singapore
2004;33(4):467-472.
45. Asma A, Maizaton AA. Kimura's disease: an unusual cause of cervical tumor. Med J
Malaysia 2005;60(3):373-376
http://www.e-mjm.org/2005/v60n3/Kimuras_Disease.pdf.
46. Ab Hamid S, Wastie ML. Primary non-Hodgkin's lymphoma presenting as a uterine
cervical mass. Singapore Med J 2008;49(3):e73-5
http://smj.sma.org.sg/4903/4903cr4.pdf.
47. Shanthi V, Majdah M, Syed Aljunid, et al. Cervical cancer in Malaysia: can we improve
our screening and preventive practice? BMC Public Health 2012;12(Suppl 2):A17
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507984/pdf/1471-2458-12-S2-A17.pdf.
48. Sharifa Ezat WP, Aljunid SM, Ng P, et al. Quality of life among preinvasive and invasive
cervical cancer in Malaysia. ASEAN Journal of Psychiatry 2009;10(2):115-126
http://www.aseanjournalofpsychiatry.org/pdf/2ASEAN_3_Ezat.pdf.
49. Devi Beena CR, Tang TS, Gerard LC. Preliminary results from the pilot study on the
National Cancer Patient Registry--Cervical Cancer. Med J Malaysia 2008;63 Suppl C:63-65
50. Norodiyah O, Othman NH. Adequacy of cellular material in split-sampling of cervical
scrapings for routine cancer screening: an analysis of 702 smears. Malays J Pathol
2012;34(2):115-121
http://www.mjpath.org.my/2012.2/cancer-screening.pdf.
51. Saini R, Shen TH, Othman NH, et al. Evaluation of polymerase chain reaction (PCR)
method and hybrid capture II (HCII) assay for the detection of human papillomavirus in
cervical scrapings. Med J Malaysia 2007;62(3):206-209
http://www.e-mjm.org/2007/v62n3/Human_Papillomavirus.pdf.
52. Tran NT, Taylor R, Choe SI, et al. Knowledge, attitude and practice (KAP) concerning
cervical cancer and screening among rural and urban female healthcare practitioners in
the Democratic People's Republic of Korea. Asian Pac J Cancer Prev 2011;12(11):30233028.
53. Quek SC, Lim BK, Domingo E, et al. Human papillomavirus type distribution in invasive
cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
Int J Gynecol Cancer 2013;23(1):148-156.
54. Chong PP, Asyikin N, Rusinahayati M, et al. High prevalence of human papillomavirus
DNA detected in cervical swabs from women in southern Selangor, Malaysia. Asian Pac J
Cancer Prev 2010;11(6):1645-1651
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%20164551%2011.03%20P%20P%20Chong.pdf.
55. Cheah PL, Looi LM, Sivanesaratnam V. Human papillomavirus in cervical cancers of
Malaysians. J Obstet Gynaecol Res 2011;37(6):489-495.
56. Tay SK, Tay YK. The prevalence and significance of high-risk human papillomavirus DNA
test in southern Malaysia and Singapore. Aust N Z J Obstet Gynaecol 2009;49(3):323-327.
57. Chow SN, Soon R, Park JS, et al. Knowledge, attitudes, and communication around
human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians.
Vaccine 2010;28(22):3809-3817.
58. Wong LP, Sam IC. Ethnically diverse female university students' knowledge and
attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J
Obstet Gynecol Reprod Biol 2010;148(1):90-95.
59. Farzaneh F, Shirvani HE, Barouti E, et al. Knowledge and attitude of women regarding
the human papillomavirus (HPV) infection, its relationship to cervical cancer and
prevention methods. Med J Malaysia 2011;66(5):468-473
http://www.e-mjm.org/2011/v66n5/Human_Papillomavirus.pdf.
60. Naing C, Pereira J, Abe T, et al. Predictors associated with the willingness to take
human papilloma virus vaccination. J Community Health 2012;37(2):288-293.
61. Wong LP. Knowledge and attitudes about HPV infection, HPV vaccination, and cervical
cancer among rural southeast Asian women. Int J Behav Med 2011;18(2):105-111.
62. Sam IC, Wong LP, Rampal S, et al. Maternal acceptance of human papillomavirus
vaccine in Malaysia. J Adolesc Health 2009;44(6):610-612.
63. Wong LP. HPV information needs, educational messages and channel of delivery
preferences: views from developing country with multiethnic populations. Vaccine
2009;27(9):1410-1415.
64. Domingo EJ, Noviani R, Noor MR, et al. Epidemiology and prevention of cervical cancer
in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine 2008;26 Suppl
12:M71-9.
65. Wong LP. Physicians' experiences with HPV vaccine delivery: evidence from developing
country with multiethnic populations. Vaccine 2009;27(10):1622-1627.
HEALTH BEHAVIOUR:
66. Nor Hayati O, Beena CD, Halimah Y. Cervical cancer screening: patients understanding
in major hospitals in Malaysia. Asian Pac J Cancer Prev 2009;10(4):569-574
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No4/c
%20569%20Othman.pdf.
67. Rima Marhayu AR, Majdah M, Zaleha AH, et al. Is the phone call the most effective
method for recall in cervical cancer screening? - results from a randomised control trial.
Asian Pac J Cancer Prev 2013;14(10):5901-5904
http://www.ncbi.nlm.nih.gov/pubmed/24289597
68. Rima Marhayu AR, Maznah D. Study protocol for the most effective recall method in a
cervical cancer screening program in Klang, Malaysia. Asian Pac J Cancer Prev
2013;14(10):5867-5870
http://www.ncbi.nlm.nih.gov/pubmed/24289591
69. Rima Marhayu AR, Maznah D, Majdah M, et al. Adapting the Australian system: is an
organized screening program feasible in Malaysia?--an overview of cervical cancer
screening in both countries. Asian Pac J Cancer Prev 2013;14(3):2141-2146
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No3/21412146%202.5%20Rima%20Marhayu%20Abdul%20Rashid_1.pdf.
70. Al-Naggar RA, Al-Jashamy K, Chen R. Perceptions and opinions regarding human
papilloma virus vaccination among young women in Malaysia. Asian Pac J Cancer Prev
2010;11(6):1515-1521
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c%20151521%2010.21%20Redhwan%20Ahmed%20Al-Naggar.pdf.
71. Farveen Marican AB, Nik Raihan NM, Nor Hayati O. Clinicopathological comparison of
adenocarcinoma of cervix and endometrium using cell cycle markers: P16ink4a, P21waf1,
and p27Kip1 on 132 cancers. Infect Dis Obstet Gynecol 2011;2011:857851
http://web.ebscohost.com.ezp.imu.edu.my/ehost/pdfviewer/pdfviewer?sid=71afbef8-5f1c44f2-9fd8-5931a898c0b7%40sessionmgr4003&vid=4&hid=4112.
72. Nuradhiathy AR, Khattak M, Yong Zulina Z, et al. Estimating the five-year survival of
cervical cancer patients treated in hospital universiti sains malaysia. Asian Pac J Cancer
Prev 2013;14(2):825-828
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No2/82528%201.15%20Nuradhiathy%20Abd%20Razak.pdf.
73. Woo YL, Sharina MR, Chong KR, et al. Does the success of a school-based HPV vaccine
programme depend on teachers' knowledge and religion? -- A survey in a multicultural
society. Asian Pac J Cancer Prev 2012;13(9):4651-4654
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No9/4651-54%208.13%20Yin
%20Ling%20Woo.pdf.
74. Al-Naggar RA, Bobryshev YV, Al-Jashamy K, et al. Practice of HPV vaccine and
associated factors among school girls in Melaka, Malaysia. Asian Pac J Cancer Prev
2012;13(8):3835-3840
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No8/383540%205.7%20Redhwan%20Ahmed%20Al-Naggar%20%28girls%20in%20Malaka%29.pdf.
HEALTH BEHAVIOUR:
75. Hesham HR, Nur Zakiah, N Mohd Saat, Dahlia Nadira AM. Knowledge, attitude and
practice of malaysian medical and pharmacy students towards human papillomavirus
vaccination. Asian Pac J Cancer Prev 2012;13(5):2279-2283
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No5/227983%2010.6%20Hesham%20H%20Rashwan.pdf.
76. Al-Naggar RA, Bobryshev YV. Practice towards human papillomavirus vaccines among
Malaysian women: a survey of a general youth population. Asian Pac J Cancer Prev
2011;12(8):2045-2049
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No8/2045-49%20c7.30%20AlNaggar.pdf.
77. Hesham R, Syarif Husin L, Kiat AN. Knowledge of cervical cancer and acceptance of
HPV vaccination among secondary school students in Sarawak, Malaysia. Asian Pac J
Cancer Prev 2011;12(7):1837-1841
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No7/1837-1841%20c
%206.27%20Hesham%20Rashwan.pdf
78. Khoo CL, Teoh S, Abdul Rashid Khan, et al. Awareness of cervical cancer and HPV
vaccination and its affordability among rural folks in Penang Malaysia. Asian Pac J Cancer
Prev 2011;12(6):1429-1433
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No6/1429-1433%20c
%205.11%20Chung%20Lee%20Khoo.pdf.
79. Fauziah A, Norlaili AA, Su TT. Factors related to poor practice of Pap smear screening
among secondary school teachers in Malaysia. Asian Pac J Cancer Prev 2011;12(5):13471352
http://www.apocpcontrol.org/paper_file/issue_abs/Volume12_No5/1347-1352%20c
%204.17%20Fauziah%20Abdullah.pdf.
80. Syed M Aljunid, Zafar A, Saperi S, et al. Burden of disease associated with cervical
cancer in Malaysia and potential costs and consequences of HPV vaccination. Asian Pac J
Cancer Prev 2010;11(6):1551-1559
www.apocpcontrol.org/paper_file/issue_abs/Volume11_No6/c 1551-59 10.25 S Aljunid.pdf.
81. Fauziah A, Su TT. Enhancement of the cervical cancer screening program in Malaysia: a
qualitative study. Asian Pac J Cancer Prev 2010;11(5):1359-1366
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No5/c%201359-66%20Fauziah
%20Abdullah.pdf.
82. Sharifa Ezat WP, Syed Aljunid. Cost-effectiveness of HPV vaccination in the prevention
of cervical cancer in Malaysia. Asian Pac J Cancer Prev 2010;11(1):79-90
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No1/79%20c%20Sharif
%20Ezat.pdf.
83. Sharifa Ezat WP, Syed Aljunid. Comparative cost-effectiveness of HPV vaccines in the
prevention of cervical cancer in Malaysia. Asian Pac J Cancer Prev 2010;11(4):943-951
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No4/c%20943-51%20Ezat.pdf.
84. Sharifa Ezat WP, Rozita H, Jamsiah M, et al. National HPV immunisation programme:
knowledge and acceptance of mothers attending an obstetrics clinic at a teaching
hospital, Kuala Lumpur. Asian Pac J Cancer Prev 2013;14(5):2991-2999
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No5/299199%204.8%20Sharifa%20Ezat%20.pdf
85. Nor Hayati O, Rebolj M. Challenges to cervical screening in a developing country: the
case of Malaysia. Asian Pac J Cancer Prev 2009;10(5):747-752
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No5/747%20c%20Nor
%20Hayati%20.pdf.
86. Sharifah Noor Akmal, Seeni A, Nurismah M, et al. Prevalence of human papillomavirus
in abnormal cervical smears in Malaysian patients. Asian Pac J Cancer Prev
2009;10(2):303-306.
87. Sharifa Ezat WP, Sharifah NA, Sayyidi Hamzi A, et al. Prevalence of human
papillomavirus genotypes in preinvasive and invasive cervical cancer-A UKM study. Med
Health 2010;5(2):66-76
http://journalarticle.ukm.my/2071/1/06-MS_084_-_proof__66-76_.pdf.
88. Tan GC, Sharifah Noor Akmal, Shiran MS, et al. Utility of Ki-67 and p53 in distinguishing
cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix. Asian Pac J
Cancer Prev 2008;9(4):781-784
http://www.apocpcontrol.org/paper_file/issue_abs/Volume9_No4/781%20c%20Tan.pdf.
89. Mohamad Nasir S, Nazimah I, Rushdan MN. The Role of Computed Tomography (CT)
Scan in Assessment of the Parametrial Involvement in Early Stage Cervical Carcinoma.
Journal of Surgical Academia 2012;2(1):14
http://journalarticle.ukm.my/5179/1/04-MS1056%2814-17%29.pdf.
90. Shafiee M, NorAzlin M, Lim P, et al. Emergency chemotherapy’ for bleeding cervical
cancer: case series. Journal of Surgical Academia 2012;2(2):35
http://journalarticle.ukm.my/5942/1/09-MS1066_%2835-37%29_1.pdf.
91. Aishah AM, Osman A. Knowledge, attitude and practice among midwives and
community nurses on cervical cancer in the state of Kedah in 1997. Jurnal Kesihatan
Masyarakat 2006;12(1).
92. Al-Jashamy K, Al-Naggar RA, San P, et al. Histopathological findings for cervical lesions
in Malaysian women. Asian Pac J Cancer Prev 2009;10(6):1159-1162
http://www.apocpcontrol.org/paper_file/issue_abs/Volume10_No6/1159_c_Al-Jashamy.pdf.
93. Rima Marhayu AR, Majdah M, Zaleha AH, et al. Is the phone call the most effective
method for recall in cervical cancer screening? - results from a randomised control trial.
Asian Pac J Cancer Prev 2013;14(10):5901-5904
http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No10/59015904%207.17%20Rima%20Marhayu%20Abdul%20Rashid.pdf.
94. Sharifa Ezat WP, Norin Rahayu S, Sharifah Noor Akmal, Syed Hussain, et al. HPV
Positivity and its’ Influencing factors among invasive cervical cancer women in Malaysia.
International Journal of Public Health Research. International Journal of Public Health
Research 2011;1(1):13
http://journalarticle.ukm.my/3340/1/vol%25201%2520no%25201%25202011_3.pdf.
95. Ahmad Bustamam A, Abdelwahab SI, Johari J, et al. Combination of zerumbone and
cisplatin to treat cervical intraepithelial neoplasia in female BALB/c mice. Int J Gynecol
Cancer 2009;19(6):1004-1010
http://ovidsp.tx.ovid.com.ezp.imu.edu.my/sp
3.10.0b/ovidweb.cgi?
WebLinkFrameset=1&S=GIPIFPAMIPDDPEEINCNKLEJCOPCJAA00&returnUrl=ovidweb.cgi
%3f%26Titles%3dS.sh.43%257c1%257c10%26FORMAT%3dtitle%26FIELDS%3dTITLES
%26S%3dGIPIFPAMIPDDPEEINCNKLEJCOPCJAA00&directlink=http%3a%2f
%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCJCLEEIIP00%2ffs047%2fovft%2flive
%2fgv031%2f00009577%2f00009577-20090800000004.pdf&filename=Combination+of+Zerumbone+and+Cisplatin+to+Treat+Cervical+In
traepithelial+Neoplasia+in+Female+BALB
%2fc+Mice.&navigation_links=NavLinks.S.sh.43.1&PDFIdLinkField=%2ffs047%2fovft
%2flive%2fgv031%2f00009577%2f00009577200908000-00004&link_from=S.sh.43; 1&pdf_key=B&pdf_index=S.sh.43&D=yrovft.
96. Al-Naggar RA, Zaleha MI. Perception and opinion of medical students about Pap smear
test: a qualitative study. Asian Pac J Cancer Prev 2010;11(2):435-440
http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No2/435%20Redhwan
%20Ahmed%20Al-Naggar.pdf.
97. Alsaad MA, Khadijah S, Fariza F. Knowledge towards HPV infection and HPV vaccines
among Syrian mothers. Asian Pac J Cancer Prev 2012;13(3):879-883
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No3/87983%202.17%20Mohammed%20Alsaad.pdf.
98. Cheah PL, Looi L, Teoh KH, et al. p16(INK4a) is a useful marker of human
papillomavirus integration allowing risk stratification for cervical malignancies. Asian Pac J
Cancer Prev 2012;13(2):469-472
http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No2/46972%201.9%20Cheah.pdf.
99. Rashwan H, Ishak I, Sawalludin N. Knowledge and views of secondary school students
in Kuala Lumpur on cervical cancer and its prevention. Asian Pac J Cancer Prev
2013;14(4):2545-2549.
100. Cheah PL, Looi LM, Ng MH, et al. Telomerase activation and human papillomavirus
infection in invasive uterine cervical carcinoma in a set of Malaysian patients. J Clin Pathol
2002;55(1):22-26
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769559/.
101. Farooqui M, Hassali MA, Knight A, et al. A qualitative exploration of Malaysian cancer
patients' perceptions of cancer screening. BMC Public Health 2013;13:48-2458-13-48
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564681/.
102. Gravitt PE. Evidence and impact of human papillomavirus latency. Open Virol J
2012;6:198-203
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547385/.
103. Gravitt PE. The known
2011;121(12):4593-4599
unknowns
of
HPV
natural
history.
J
Clin
Invest
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225991/.
104. Ramasamy S, Abdul Wahab N, Zainal Abidin N, et al. Growth inhibition of human
gynecologic and colon cancer cells by Phyllanthus watsonii through apoptosis induction.
PLoS One 2012;7(4):e34793
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335034/.
105. Saini R, Khim TP, Rahman SA, et al. High-risk human papillomavirus in the oral cavity
of women with cervical cancer, and their children. Virol J 2010;7:131-422X-7-131
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901268/.